Karol Kaltenbach

TitleProfessor
InstitutionThomas Jefferson University
DepartmentFamily Cntr/My Sister's Place
Address1233 Locust Street
Philadelphia PA 19107
Phone205-955-4068
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Link HM, Jones H, Miller L, Kaltenbach K, Seligman NS. Buprenorphine-Naloxone Use in Pregnancy, a subgroup analysis of medication to treat opioid use disorder. Am J Obstet Gynecol MFM. 2021 Apr 05; 100369. PMID: 33831585.
      Citations:    
    2. Link HM, Jones H, Miller L, Kaltenbach K, Seligman N. Buprenorphine-naloxone use in pregnancy: a systematic review and metaanalysis. Am J Obstet Gynecol MFM. 2020 Aug; 2(3):100179. PMID: 33345863.
      Citations:    
    3. Jones HE, Kaltenbach K, Benjamin T, Wachman EM, O'Grady KE. Letter-in-reply. J Addict Med. 2020 Jan 14. PMID: 31972769.
      Citations:    
    4. Kaltenbach K. Assessment of the newborn prenatally exposed to drugs: The history. Semin Fetal Neonatal Med. 2019 Feb 04. PMID: 30744981.
      Citations:    
    5. Jones HE, Kaltenbach K, Benjamin T, Wachman EM, O'Grady KE. Prenatal Opioid Exposure, Neonatal Abstinence Syndrome/Neonatal Opioid Withdrawal Syndrome, and Later Child Development Research: Shortcomings and Solutions. J Addict Med. 2018 Oct 16. PMID: 30334926.
      Citations:    
    6. Jones HE, O'Grady KE, Kaltenbach K. Reconsidering retrospective review of neurodevelopmental outcomes in infants treated for neonatal abstinence syndrome. J Perinatol. 2018 Sep; 38(9):1280-1281. PMID: 30061590.
      Citations:    
    7. Kaltenbach K, O'Grady KE, Heil SH, Salisbury AL, Coyle MG, Fischer G, Martin PR, Stine S, Jones HE. Prenatal exposure to methadone or buprenorphine: Early childhood developmental outcomes. Drug Alcohol Depend. 2018 Feb 01; 185:40-49. PMID: 29413437.
      Citations:    
    8. Gannon M, Mackenzie M, Kaltenbach K, Abatemarco D. Impact of Mindfulness-Based Parenting on Women in Treatment for Opioid Use Disorder. J Addict Med. 2017 Jul 25. PMID: 28746242.
      Citations:    
    9. Short VL, Gannon M, Weingarten W, Kaltenbach K, LaNoue M, Abatemarco DJ. Reducing Stress Among Mothers in Drug Treatment: A Description of a Mindfulness Based Parenting Intervention. Matern Child Health J. 2017 Jun; 21(6):1377-1386. PMID: 28078528.
      Citations:    
    10. Kraft WK, Adeniyi-Jones SC, Chervoneva I, Greenspan JS, Abatemarco D, Kaltenbach K, Ehrlich ME. Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome. N Engl J Med. 2017 06 15; 376(24):2341-2348. PMID: 28468518.
      Citations:    
    11. Kaltenbach K, Jones HE. Neonatal Abstinence Syndrome: Presentation and Treatment Considerations. J Addict Med. 2016 Jul-Aug; 10(4):217-23. PMID: 26974659.
      Citations:    
    12. Jones HE, Kaltenbach K, Johnson E, Seashore C, Freeman E, Malloy E. Neonatal Abstinence Syndrome: Presentation and Treatment Considerations. J Addict Med. 2016 Jul-Aug; 10(4):224-8. PMID: 27244045.
      Citations:    
    13. Desai RJ, Huybrechts KF, Hernandez-Diaz S, Mogun H, Patorno E, Kaltenbach K, Kerzner LS, Bateman BT. Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study. BMJ. 2015; 350:h2102. PMID: 25975601.
      Citations:    
    14. Jones HE, Jansson LM, O'Grady KE, Kaltenbach K. The relationship between maternal methadone dose at delivery and neonatal outcome: methodological and design considerations. Neurotoxicol Teratol. 2013 Sep-Oct; 39:110-5. PMID: 24099621.
      Citations:    
    15. Holbrook AM, Jones HE, Heil SH, Martin PR, Stine SM, Fischer G, Coyle MG, Kaltenbach K. Induction of pregnant women onto opioid-agonist maintenance medication: An analysis of withdrawal symptoms and study retention. Drug Alcohol Depend. 2013 Sep 1; 132(1-2):329-34. PMID: 23523131.
      Citations:    
    16. O'Grady KE, Jones HE, Jansson LM, Kaltenbach K. Response to Wouldes and Woodward: maternal methadone dose during pregnancy and infant clinical outcome. Neurotoxicol Teratol. 2013 Sep-Oct; 39:116-8. PMID: 23416427.
      Citations:    
    17. Chisolm MS, Fitzsimons H, Leoutsakos JM, Acquavita SP, Heil SH, Wilson-Murphy M, Tuten M, Kaltenbach K, Martin PR, Winklbaur B, Jansson LM, Jones HE. A comparison of cigarette smoking profiles in opioid-dependent pregnant patients receiving methadone or buprenorphine. Nicotine Tob Res. 2013 Jul; 15(7):1297-304. PMID: 23288871.
      Citations:    
    18. Jones HE, Heil SH, Tuten M, Chisolm MS, Foster JM, O'Grady KE, Kaltenbach K. Cigarette smoking in opioid-dependent pregnant women: Neonatal and maternal outcomes. Drug Alcohol Depend. 2013 Aug 1; 131(3):271-7. PMID: 23279924.
      Citations:    
    19. Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, O'Grady KE, Selby P, Martin PR. Nonserious adverse events in randomized trials with opioid-dependent pregnant women: direct versus indirect measurement. Am J Addict. 2012 Nov; 21 Suppl 1:S1-4. PMID: 23786504.
      Citations:    
    20. Jones HE, Heil SH, Baewert A, Arria AM, Kaltenbach K, Martin PR, Coyle MG, Selby P, Stine SM, Fischer G. Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review. Addiction. 2012 Nov; 107 Suppl 1:5-27. PMID: 23106923.
      Citations:    
    21. Jones HE, Fischer G, Heil SH, Kaltenbach K, Martin PR, Coyle MG, Selby P, Stine SM, O'Grady KE, Arria AM. Maternal Opioid Treatment: Human Experimental Research (MOTHER)-approach, issues and lessons learned. Addiction. 2012 Nov; 107 Suppl 1:28-35. PMID: 23106924.
      Citations:    
    22. Salisbury AL, Coyle MG, O'Grady KE, Heil SH, Martin PR, Stine SM, Kaltenbach K, Weninger M, Jones HE. Fetal assessment before and after dosing with buprenorphine or methadone. Addiction. 2012 Nov; 107 Suppl 1:36-44. PMID: 23106925.
      Citations:    
    23. Kaltenbach K, Holbrook AM, Coyle MG, Heil SH, Salisbury AL, Stine SM, Martin PR, Jones HE. Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication. Addiction. 2012 Nov; 107 Suppl 1:45-52. PMID: 23106926.
      Citations:    
    24. Gaalema DE, Scott TL, Heil SH, Coyle MG, Kaltenbach K, Badger GJ, Arria AM, Stine SM, Martin PR, Jones HE. Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates. Addiction. 2012 Nov; 107 Suppl 1:53-62. PMID: 23106927.
      Citations:    
    25. Benningfield MM, Dietrich MS, Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, O'Grady KE, Fischer G, Martin PR. Opioid dependence during pregnancy: relationships of anxiety and depression symptoms to treatment outcomes. Addiction. 2012 Nov; 107 Suppl 1:74-82. PMID: 23106929.
      Citations:    
    26. Holbrook AM, Baxter JK, Jones HE, Heil SH, Coyle MG, Martin PR, Stine SM, Kaltenbach K. Infections and obstetric outcomes in opioid-dependent pregnant women maintained on methadone or buprenorphine. Addiction. 2012 Nov; 107 Suppl 1:83-90. PMID: 23106930.
      Citations:    
    27. McNicholas LF, Holbrook AM, O'Grady KE, Jones HE, Coyle MG, Martin PR, Heil SH, Stine SM, Kaltenbach K. Effect of hepatitis C virus status on liver enzymes in opioid-dependent pregnant women maintained on opioid-agonist medication. Addiction. 2012 Nov; 107 Suppl 1:91-7. PMID: 23106931.
      Citations:    
    28. Jones HE, Heil SH, Kaltenbach K, Stine SM, Coyle MG, Arria AM, O'Grady KE, Selby P, Martin PR. Comments on: Efficacy versus Effectiveness of Buprenorphine and Methadone Maintenance in Pregnancy. J Addict Dis. 2012 Oct; 31(4):321-6. PMID: 23244549.
      Citations:    
    29. Jones HE, Kaltenbach K. Neonatal abstinence syndrome. JAMA. 2012 Aug 22; 308(8):762-3; author reply 763. PMID: 22910747.
      Citations:    
    30. Holbrook A, Kaltenbach K. Co-occurring psychiatric symptoms in opioid-dependent women: the prevalence of antenatal and postnatal depression. Am J Drug Alcohol Abuse. 2012 Nov; 38(6):575-9. PMID: 22783870.
      Citations:    
    31. Jones HE, Finnegan LP, Kaltenbach K. Methadone and buprenorphine for the management of opioid dependence in pregnancy. Drugs. 2012 Apr 16; 72(6):747-57. PMID: 22512363.
      Citations:    
    32. Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, O'Grady KE, Selby P, Martin PR, Jansson L, Fischer G. Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus? J Matern Fetal Neonatal Med. 2012 Jul; 25(7):1197-201. PMID: 22292518.
      Citations:    
    33. Chisolm MS, Acquavita SP, Kaltenbach K, Winklbaur B, Heil SH, Martin PR, Stine SM, Coyle M, Leoutsakos JM, Tuten M, Jansson LM, Backer PM, Jones HE. Cigarette Smoking and Neonatal Outcomes in Depressed and Non-Depressed Opioid-Dependent Agonist-Maintained Pregnant Patients. Addict Disord Their Treat. 2011 Dec; 10(4):180-187. PMID: 22833702.
      Citations:    
    34. Holbrook AM, Kaltenbach KA. Effectiveness of a smoking cessation intervention for methadone-maintained women: a comparison of pregnant and parenting women. Int J Pediatr. 2011; 2011:567056. PMID: 21822438.
      Citations:    
    35. Jones HE, Jansson LM, Kaltenbach K. Methadone and perinatal outcomes: another perspective. Am J Obstet Gynecol. 2011 Nov; 205(5):e11; author's reply e11-12. PMID: 21784398.
      Citations:    
    36. Jones HE, Kaltenbach K, O'Grady KE. Methadone and the causes of maternal and perinatal complications: a response to Pinto et al. "Substance abuse during pregnancy: effect on pregnancy outcomes" [Eur. J. Obstet. Gynecol. Reprod. Biol. 150 (2010) 137-141]. Eur J Obstet Gynecol Reprod Biol. 2011 Sep; 158(1):116-7; author reply 117. PMID: 21620557.
      Citations:    
    37. Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, O'Grady KE, Selby P, Martin PR, Fischer G. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 2010 Dec 9; 363(24):2320-31. PMID: 21142534.
      Citations:    
    38. Jones HE, Harrow C, O'Grady KE, Crocetti M, Jansson LM, Kaltenbach K. Neonatal abstinence scores in opioid-exposed and nonexposed neonates: a blinded comparison. J Opioid Manag. 2010 Nov-Dec; 6(6):409-13. PMID: 21269001.
      Citations:    
    39. Heil SH, Jones HE, Arria A, Kaltenbach K, Coyle M, Fischer G, Stine S, Selby P, Martin PR. Unintended pregnancy in opioid-abusing women. J Subst Abuse Treat. 2011 Mar; 40(2):199-202. PMID: 21036512.
      Citations:    
    40. Kraft WK, Dysart K, Greenspan JS, Gibson E, Kaltenbach K, Ehrlich ME. Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome. Addiction. 2011 Mar; 106(3):574-80. PMID: 20925688.
      Citations:    
    41. Benningfield MM, Arria AM, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Fischer G, Jones HE, Martin PR. Co-occurring psychiatric symptoms are associated with increased psychological, social, and medical impairment in opioid dependent pregnant women. Am J Addict. 2010 Sep-Oct; 19(5):416-21. PMID: 20716304.
      Citations:    
    42. Holbrook A, Kaltenbach K. Gender and NAS: does sex matter? Drug Alcohol Depend. 2010 Nov 1; 112(1-2):156-9. PMID: 20576365.
      Citations:    
    43. Martin PR, Arria AM, Fischer G, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Selby P, Jones HE. Psychopharmacologic management of opioid-dependent women during pregnancy. Am J Addict. 2009 Mar-Apr; 18(2):148-56. PMID: 19283567.
      Citations:    
    44. Stine SM, Heil SH, Kaltenbach K, Martin PR, Coyle MG, Fischer G, Arria AM, Selby P, Jones HE. Characteristics of opioid-using pregnant women who accept or refuse participation in a clinical trial: screening results from the MOTHER study. Am J Drug Alcohol Abuse. 2009; 35(6):429-33. PMID: 20014912.
      Citations:    
    45. Jones HE, Kaltenbach K, O'Grady KE. The complexity of examining developmental outcomes of children prenatally exposed to opiates. A response to the Hunt et al. Adverse neurodevelopmental outcome of infants exposed to opiates in-utero. Early Human Development (2008, 84, 29-35). Early Hum Dev. 2009 Apr; 85(4):271-2. PMID: 19008056.
      Citations:    
    46. Kraft WK, Gibson E, Dysart K, Damle VS, Larusso JL, Greenspan JS, Moody DE, Kaltenbach K, Ehrlich ME. Sublingual buprenorphine for treatment of neonatal abstinence syndrome: a randomized trial. Pediatrics. 2008 Sep; 122(3):e601-7. PMID: 18694901.
      Citations:    
    47. Jones HE, Martin PR, Heil SH, Kaltenbach K, Selby P, Coyle MG, Stine SM, O'Grady KE, Arria AM, Fischer G. Treatment of opioid-dependent pregnant women: clinical and research issues. J Subst Abuse Treat. 2008 Oct; 35(3):245-59. PMID: 18248941.
      Citations:    
    48. Dysart K, Hsieh HC, Kaltenbach K, Greenspan JS. Sequela of preterm versus term infants born to mothers on a methadone maintenance program: differential course of neonatal abstinence syndrome. J Perinat Med. 2007; 35(4):344-6. PMID: 17511598.
      Citations:    
    49. Berghella V, Lim PJ, Hill MK, Cherpes J, Chennat J, Kaltenbach K. Maternal methadone dose and neonatal withdrawal. Am J Obstet Gynecol. 2003 Aug; 189(2):312-7. PMID: 14520184.
      Citations:    
    50. Comfort M, Sockloff A, Loverro J, Kaltenbach K. Multiple predictors of substance-abusing women's treatment and life outcomes: a prospective longitudinal study. Addict Behav. 2003 Mar; 28(2):199-224. PMID: 12573675.
      Citations:    
    51. Drozdick J, Berghella V, Hill M, Kaltenbach K. Methadone trough levels in pregnancy. Am J Obstet Gynecol. 2002 Nov; 187(5):1184-8. PMID: 12439500.
      Citations:    
    52. Comfort M, Kaltenbach KA. Predictors of Treatment Outcomes for Substance-Abusing Women: A Retrospective Study. Subst Abus. 2000 Mar; 21(1):33-45. PMID: 12466646.
      Citations:    
    53. Kaltenbach K, Finnegan L. Prevention and Treatment Issues for Pregnant Cocaine-Dependent Women and Their Infants. Ann N Y Acad Sci. 1998 Jun; 846(1):329-334. PMID: 29087563.
      Citations:    
    Kaltenbach's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (88)
    Explore
    _
    Co-Authors (8)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _